Top compounds associated with response to SLC16A9


Feature Type Standardized
Nominal ANOVA
mRNA AT-7519 GDSC1000 pan-cancer AAC -0.0038 0.9
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0065 0.9
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.0041 0.9
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.0044 0.9
mRNA CAL-101 GDSC1000 pan-cancer AAC 0.0037 0.9
mRNA AC220 GDSC1000 pan-cancer AAC 0.004 0.9
mRNA KW-2449 CTRPv2 pan-cancer AAC -0.0035 0.9
mRNA Lisitinib GDSC1000 pan-cancer AAC -0.0038 0.9
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.0031 0.9
mRNA Talazoparib GDSC1000 pan-cancer AAC 0.0036 0.9
Download CSV